EUVIMEDEUVIMED entdecken
Crossref

Elucidation of the compatibility mechanism of Yuanhuzhitong prescription in view of CYP-mediated herbal inter-component interactions

Zhenzhen Li, Xingyan Zhang, Qiaoqiao Han, Xiaolei Zhou, Tao Cui, Sen Liu, Tianyu Zhao, Weidang Wu, Xiaoliang Wang, Ze Wang, Xiulin Yi, Fengying Yan

Fitoterapia · 2025

DOI: 10.1016/j.fitote.2025.106934 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fitoterapia, 2025. Verfasst von Zhenzhen Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, Tianjin 300301, …. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Cytochrome P-450 Enzyme System, Cytochrome P-450 Enzyme Inhibitors, Herb-Drug Interactions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Tianjin Municipal Science and Technology Program, Chinese Academy of Medical Sciences Initiative for Innovative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Yuanhuzhitong prescription (YZP), composed by Corydalis yanhusuo and Angelica dahurica, is mainly used to treat stomach pain, rib pain, headache. However, there is limited information on the effects of YZP on the activity of CYP450 enzymes, and studies on the compatibility mechanism of YZP in view of CYP-mediated herb-herb interactions are rarely conducted. This study, utilizing probe substrates, human liver microsomes, recombinant CYP metabolic enzymes, CYP inhibitors, and molecular docking, focuses on the metabolic stability and inhibitory activity of YZP components on P450 isozymes, and how imperatorin (IPT) and isoimperatorin (IIP) affect the elimination pathway of tetrahydropalmatine (THP) by inhibiting the activity of the CYP450 enzyme to enhance the analgesic efficacy of CYH. The results showed that THP shows weak inhibition of CYP2C9, CYP2D6, and 3A4; while IPT and IIP are potent inhibitors of CYP1A2, moderate inhibitors of CYP2C19, CYP2C9, CYP2D6, and 3A4. In addition, CYP2B6 was strongly inhibited by IPT and moderately inhibited by IIP. THP is primarily metabolized by CYP1A2, CYP2C9, CYP2D6, and CYP3A4. IPT and IIP undergo metabolism mainly through CYP1A2, CYP2B6, CYP2C19, and 3A4. Molecular docking studies confirmed that THP, IPT and IIP occupy the active sites of CYP1A2, CYP2C9, CYP2D6, and CYP3A4. In vitro and in vivo experiments have shown a significant reduction in metabolism of THP in combination with IPT or IIP. IPT and IIP mediate the metabolism of THP in the liver by inhibiting P450 enzymes, thereby enhancing the bioavailability of THP, reducing the elimination rate of THP, and consequently improving the analgesic efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalCytochrome P-450 Enzyme SystemCytochrome P-450 Enzyme InhibitorsHerb-Drug InteractionsCorydalisAngelicaHumansMolecular Docking SimulationMicrosomes, LiverBerberine AlkaloidsFurocoumarinsMolecular Structure

Stichwörter der Autor:innen

CYP1A2CYP2C9CYP2D6CYP3A4Herb-herb interactionYuanhuzhitong prescription

Substanzen

Drugs, Chinese HerbalCytochrome P-450 Enzyme SystemCytochrome P-450 Enzyme InhibitorsBerberine AlkaloidstetrahydropalmatineFurocoumarinsimperatorin

Autor:innen und Institutionen

  • State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, Tianjin 300301, China.
  • Shenyang Pharmaceutical University, Shenyang 110016, China.
  • State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, Tianjin 300301, China; Biohit Healthcare (Hefei) Co., Ltd., Hefei 2300000, China.
  • State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, Tianjin 300301, China. Electronic address: zhouxiaolei@tipr.com.cn.
  • State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, Tianjin 300301, China; Shenyang Pharmaceutical University, Shenyang 110016, China.
  • State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin Institute of Pharmaceutical Research, Tianjin 300301, China. Electronic address: zhaotianyu@tipr.com.cn.

Förderung

  • Tianjin Municipal Science and Technology Program
  • Chinese Academy of Medical Sciences Initiative for Innovative Medicine

Zitieren

APA

Li, Z., Zhang, X., Han, Q., Zhou, X., Cui, T., Liu, S., Zhao, T., Wu, W., Wang, X., Wang, Z., Yi, X., & Yan, F. (2025). Elucidation of the compatibility mechanism of Yuanhuzhitong prescription in view of CYP-mediated herbal inter-component interactions. Fitoterapia. https://doi.org/10.1016/j.fitote.2025.106934

Vancouver

Li Z, Zhang X, Han Q, Zhou X, Cui T, Liu S, et al. Elucidation of the compatibility mechanism of Yuanhuzhitong prescription in view of CYP-mediated herbal inter-component interactions. Fitoterapia. 2025. doi:10.1016/j.fitote.2025.106934

BibTeX
@article{Li2025,
  author = {Li, Zhenzhen and Zhang, Xingyan and Han, Qiaoqiao and Zhou, Xiaolei and Cui, Tao and Liu, Sen and Zhao, Tianyu and Wu, Weidang and Wang, Xiaoliang and Wang, Ze and Yi, Xiulin and Yan, Fengying},
  title = {Elucidation of the compatibility mechanism of Yuanhuzhitong prescription in view of CYP-mediated herbal inter-component interactions},
  journal = {Fitoterapia},
  year = {2025},
  doi = {10.1016/j.fitote.2025.106934}
}
Kostenlos starten →